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ABSTRACT 
Inhibition of L. monocytogenes Growth in Dairy Products 
with Lactose Monolaurate 
by 
Yao Chen, Master of Science 
Utah State University, 2013 
Major Professor: Dr. Marie K. Walsh 
Department: Nutrition and Food Sciences 
Listeria monocytogenes leads to severe health problems and is the third leading 
cause of death among the major 5 pathogens. A synthesized novel sugar ester, lactose 
monolaurate (LML), has antimicrobial properties against Listeria monocytogenes. The 
minimum bactericidal concentration (MBC) of LML is less than 5 mg/mL (9.5 mM) in 
growth media. To determine which moiety of LML dominates in its bacteriostatic 
activities, the antibacterial effect of lactose, lauric acid and Tween 20 were tested. 
Lactose has no inhibition effect on Listeria. Lauric acid and Tween 20 had some 
antimicrobial effect (3.48 and 1.59 log reduction respectively), but did not have a 
bactericidal effect as LML did. To determine the antibacterial effect of LML on L. 
monocytogenes a 5-strain cocktail of L. monocytogenes with an initial concentration of 
approximately 5 log CFU/mL was incubated in milk, yogurt and cottage cheese. The 
effects were determined via plate counts after 24-hour incubation at 37°C. LML had at 
least a 4 log reduction and killed all the bacteria at 5 mg/mL in fat-free milk, fat-free 
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drinkable yogurt, 1% fat drinkable yogurt, and fat-free cottage cheese. LML also showed 
bacteriostatic effect in low-fat milk, whole milk, 1.5% fat drinkable yogurt, and 2% fat 
cottage cheese with a log reduction varying from 3.54 to 4.35.  These tests showed that 
the antibacterial effect of LML was related to the fat content of the dairy products as well 
as temperature. LML only inhibited Listeria at room temperature (37°C) and showed no 
inhibitive effects at refrigeration temperature (4°C). LML can inhibit the viable but 
nonculturable state of Listeria monocytogenes for up to 6 weeks at room temperature.  
 
(66 pages) 
 
 
 
 
 
 
 
 
 
 	  
	  	  
v 
PUBLIC ABSTRACT 
Inhibition of L. monocytogenes Growth in Dairy Products  
with Lactose Monolaurate 
Foodborne illness is a very severe problem, and it is now a serious issue 
throughout the world. Within the 5 pathogens that cause more than 90 percent of 
foodborne illnesses, Listeria monocytogenes ranks the third. L. monocytogenes causes the 
highest death rate among all foodborne pathogens, and it represents high risks to pregnant 
women, fetuses and people with weak immune systems. Therefore, inhibition of Listeria  
in food becomes a relevant topic in food industry and scientific field nowadays. 
Adding antibacterial agents into food products is considered as an effective 
method to inhibit Listeria growth. My research was focused on characterization of a 
novel sugar ester, lactose monolaurate (LML), with respect to antimicrobial activity.  
Previous research showed that LML was antimicrobial to L. monocytogenes with 
minimum bactericidal concentrations (MBC) less than 5 mg/mL in growth media. The 
objectives of this research were to determine if LML showed the same antibacterial  
activity in various dairy products.  
My results found that LML showed a bactericidal effect on Listeria in fat-free 
milk, fat-free drinkable yogurt, 1% drinkable yogurt, fat-free cottage cheese and 2% fat 
cottage cheese. With skim milk, whole milk and 1.5% fat yogurt, LML had bacteriostatic 
effect. Moreover, LML did not show significant inhibition on Listeria in cream. 
Therefore, the antibacterial activity of LML was dependent on the fat content of the food 
product.  
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LITERATURE REVIEW 
Synthesis of Lactose Monolaurate 
Sugar esters are available commercially (Sisterna, The Netherlands and 
Mitsubishi-Kagaku Foods Corporation, Japan) and are used in a variety of applications in 
the food, pharmaceutical, and personal care industries.  They are classified as non-ionic 
surfactants and examples include sorbitan monooleate (polysorbate 80), sucrose palmitate, 
and sucrose oleate.  They are available in a variety of hydrophilic-lipophilic balances for 
use in oil-in-water and water-in-oil emulsions (Walsh et al., 2009). Lactose monolaurate 
(LML) is a novel sugar ester recently synthesized, and it is not commercially available. 
LML was synthesized with immobilized lipases in an organic solution from vinyl laurate 
and lactose as the substrates. LML has been shown to be bactericidal against some gram-
positive microorganisms in growth media, namely L. monocytogenes and Mycobacteria 
at concentrations ranging from 1 to 5 mg/mL (Wagh et al., 2012).  This thesis will  
investigate the bactericidal activity of LML in food products. 
Foodborne Illnesses 
Foodborne illness is a very serious and worldwide problem. It has been estimated 
that 14 foodborne pathogens cause 14.1 billion in cost of illness per year. More than 90 
percent of this health burden is caused by 5 pathogens; L. monocytogenes ranks third 
after Salmonella spp and Toxoplasma gondii (Batz et al., 2011). Certain pathogen-food 
combinations have been identified as the main cause of most foodborne illness. 
According to Scallan’s estimates (Scallan et al., 2011), L. monocytogenes ranks 24th in
2	  
	  
pathogens cause annual domestic foodborne illnesses cases, and it leads 255 cases of 
death annually. 
Disease outcome trees characterize the symptoms, severities, and likelihood of 
major health states, such as hospitalization and death, associated with each of the 14 
pathogens (Batz et al., 2011), is shown below in Figure 1.  A “cost of illness” is 
associated with each health state in each tree. L. monocytogenes costs 2,655 million, 
which ranks 3rd in cost of illness among 14 food pathogens cause 14.1 billion dollars.  
	  
Figure 1. Example disease outcome tree for a hypothetical pathogen (from Batz et al.,  
2011).  
L. monocytogenes also represents risks to pregnant women and developing fetuses. 
Congenital listeriosis can lead to miscarriage, stillbirth, and neonatal death, as well as 
lifelong complications ranging from mild learning disabilities to severe mental 
impairment, permanently blurry vision, neurological disorders, and paralysis (CDC) 
(Mead et al., 1999).  
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There are a limited number of pathogen-food combinations associated with most 
foodborne illnesses (Batz et al., 2011).  L. monocytogenes in deli meat ranks third (USDA 
2010), and L. monocytogenes in dairy products ranks fifth in pathogen-food combinations 
in terms of annual disease burden (Voetsch et al., 2007). While there have been 
significant gains over the last decade in reducing contamination rates of pre-sliced, 
packaged meats (USDA, 2010), numerous studies have found that retail-sliced deli meats 
have significantly higher prevalence and levels of L. monocytogenes than pre-sliced and 
packaged meats (Gombas et al., 2003; Endrikat et al., 2010).  
L. monocytogenes is a high-risk pathogen and can cause serious health problems, 
even death. It also leads to a high financial loss every year.  Therefore, inhibiting the  
growth of L. monocytogenes in dairy and meat products will be investigated in this thesis. 
Evaluation of Potentially Hazardous Foods  
A microbiological challenge test is a method to determine if spoilage 
microorganisms, including pathogens, could grow in food and be able to cause illness 
((U.S. Food and Drug Administration, 2013). When conducting a microbiological 
challenge study, a number of factors must be considered. These include the selection of 
appropriate pathogens or surrogates, the level of challenge inoculum, the inoculum 
preparation and method of inoculation, the duration of the study, formulation factors, 
storage conditions, and sample analyses (Vestergaard, 2001).    
According to Vestergaard’s study (Vestergaard, 2001), L. monocytogenes may be 
used in challenge studies for modified atmosphere packaged products and dairy products. 
Multiple specific strains of the target pathogens are used in the challenge test.  
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The inoculum level used in the microbiological challenge study depends on 
validating a step in the process designed to reduce microbial numbers. If the inoculum 
level is too low, the product would appear to be stable or safe after the test, but actually it 
is not. On the other hand, if the inoculum level is too high, the product would not be 
stable or safe.	  When validating a process lethality step, such as heat processing or high-
pressure processing, it is usually necessary to use a high inoculum level to demonstrate 
the reduction of the target pathogens.  In microbiological challenge testing, inoculum 
preparation is an important part. The challenge organisms should be grown in specific 
media and under certain conditions for optimum growth.  
The method of inoculation is another important factor in the microbiological 
challenge testing. A specific inoculation method based on the food type must be done 
which represents the correct water activity, pH, salt level, packing and storage method of 
the product.  If the product has a high water activity (>0.96), the challenge inoculum may 
be directly inoculated into the product with mixing, using a minimal amount of sterile 
water or buffer as a carrier. One main principle is not changing the critical parameters of 
the product formulation undergoing challenge. It is recommended to use no less than 
three replicates for each sampling time throughout the challenge study (U.S. Food and 
Drug Administration, 2013).  The minimum of replicates may be variable for particular 
cases.  Other factors should be taken into consideration in the challenge study such as  
duration of the study, formulation factors and storage conditions.  
Antimicrobial Properties of Sugar Esters 
Sugar fatty-acid esters are used as emulsifiers in foods. They also have 
antimicrobial effects (Kato a d Arima, 1971; Hathcox and Beuchat, 1996). Commercial 
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sucrose esters are used mostly in Japan in canned beverages for inhibiting the growth of 
spore forming bacteria (Wang 2004).  They can be synthesized via immobilized lipases in 
an organic solvent.  The structure of LML is shown in Figure 2. 
	  
Figure 2. Atom numbering scheme for LML. 
The antimicrobial activity of sugar fatty-acid esters is related to their structure. 
The antimicrobial activity of sugar esters depends on the sugar, number and type of 
esterified fatty acids, and the degree of esterification (Smith et al., 2008). Fatty acids with 
more than 8 carbons have no inhibitory effect to Gram-negative bacteria (Devulapalle et 
al., 2004; Watanabe et al., 2000). Yeasts are inhibited by fatty acids with 10 to 12 
carbons (Piao et al., 2006). Gram-positive bacteria are less resistant to the slightly longer 
chain fatty acid ester (Ferrier et al., 2005).  
Table 1 lists some conflicting antimicrobial data on the effectiveness of sugar 
esters.  Some reports showed inhibition of Gram-negative bacteria (E. coli and Vibro 
parahaemolyticus) while others reported no inhibition.  There are three publications on 
the use of esters in food systems with inhibitory effects against some spoilage organisms 
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and foodborne pathogens (Listeria). The Sisterna products L70-C (sucrose laurate) and 
SP70-C (sucrose stearate) have selective growth-inhibiting properties and were used in 
some of the above listed studies, as were the Ryoto sugar esters P-1670 (sucrose laurate) 
and P-1670 (sucrose palmitate) from Mitsubishi.   
Recent research (Wagh et al., 2012) showed that LML is bactericidal against 4 
clinical isolates of L. monocytogenes and three different Mycobacteria.  The minimum 
bactericidal concentration (MBC) for L. monocytogenes was lower than 5 mg/mL and the 
MBC for Mycobacteria was only 1 mg/mL in bacterial growth media. 
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Table 1. Publications reporting the antimicrobial effects of sugar esters 
Ref Esters Organism Effect Medium 
Wagh et al. 
2012 
Synthesized 
lactose 
monolaurate 
Various Gram 
positive and 
Gram negative 
Bactericidal against Listeria 
monocytogenes and Mycobacteria 
Growth 
media 
Xiao et al. 
2011 
Commercial 
sucrose 
monolaurate 
E. coli 0157:H7 Strong inhibition at 10 mg/mL with 
sodium hypochlorite 
Spinach 
Habulin et 
al. 2008 
commercial and 
synthesized 
sucrose and 
fructose palmitate 
and laurate 
Bacillus cereus 
E. coli K12 
 
Strong inhibition (75-96%) against B. 
cereus with sucrose laurate at 1% 
concentration at 3 days 
Limited (10%) inhibitation against E. 
coli with all esters 
Growth 
media 
Piao et al. 
2006 
Various 
synthesized 
erythritol and 
xylitol esters 
Various Gram 
positive and 
negative 
Strong inhibitory effect with xylitol 
monolaurate against B. cereus. All 
esters were ineffective against E. coli 
Growth 
media and 
plates 
Ferrier et 
al. 2005 
Various 
synthesized sugar 
esters 
Various Gram 
positive and 
negative 
Sucrose and maltose laurate inhibited 
Bacillus at 0.5%. Limited 
inhibitation (26%) against E. coli at 
0.4%. 
Growth 
media 
Devulapalle 
et al. 2004 
Maltose laurate, 
maltotriose 
laurate, sucrose 
laurate 
Streptococcus 
mutans 
All esters suppressed the growth at 
0.05- 2% concentration of esters 
Growth 
media and 
plates 
Yang et al. 
2003 
Sucrose and 
glucose esters 
Spoilage 
organisms Z.  
bailii and L 
fructivorans 
1% sucrose esters of laurate, 
myristate or palmitate inhibited the 
growth of the organisms in salad 
dressing and were more effective 
than 0.1% sodium benzoate 
Salad 
dressing 
Watanabe 
et al. 2000 
23 different 
synthesized sugar 
esters 
Streptococcus 
mutans 
Galactose and sucrose laurates 
inhibited growth at <0.05%  
Microbial 
media 
Shearer et 
al. 2000 
Sucrose laurate, 
palmitate and 
stearate 
Bacillus and 
Clostridium 
spores 
A combined treatment of sucrose 
laurate (1%), 392 MPa pressure 
provided a 3-5.5 log10 DFU/mL 
reduction of Bacillus in milk and 
beef.   
Various 
foods 
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The synthesis efficiency of LML depends on the activity of the immobilized 
lipase and the type of organic solvent (e.g. ethanol, isopropanol, tert-amyl alcohol, 
acetone).  For each new commercial lipase used, the efficiency of LML synthesis must be 
determined; therefore, this thesis also investigated the synthesis of LML as dependent on  
the lipase and solvent.  
Regulations of Sugar Esters 
Sugar fatty-acid esters can be added into food as emulsifiers as stated in the Code 
of Federal Regulation title 21 section 170.3 (o) (8), and they are allowed in dairy 
products (U.S. Code of Federal Regulation title 21 section 172.859 (c) (1)). The usage of 
sugar esters in dairy products ranges between 0.1% (0.1 mg/mL) to 0.5% (0.5 mg/mL), 
and the maximum usage of sugar fatty acid is 5% (5 mg/mL) (U.S. Code of Federal 
Regulation title 21 section 172.859 (b) (2)).  
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HYPOTHESES AND OBJECTIVES 
The hypotheses of this study were: 
1. Synthesis of LML is influenced by various lipases. 
2.   LML is bactericidal to L. monocytogenes in foods. 
The objectives of this study were: 
1. Find the most efficient lipase to synthesize LML.  
2. Compare the bactericidal effects of LML, lauric acid, and Tween 20 in BHI media 
at 0.01 to 5 mg/mL with one strain of L. monocytogenes.  
3. Investigate the bactericidal effects of LML and lauric acid in different kinds of 
dairy products (milk, yogurt, and cheese) at concentrations from 1 to 5 mg/mL to 
find the MBC with a 5-strain cocktail of L. monocytogenes. 
4. Compare the bactericidal effects of LML in dairy products under room 
temperature and refrigerator temperature.  
5. Confirm that LML inhibited the viable but non-culturable state of a 5-strain 
cocktail of L. monocytogenes in BHI media.  	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MATERIALS AND METHODS 
Materials 
Materials and equipment included a HPLC (Beckman), microtitre well plate 
reader (HTS Ole 7000), spectrophotometer (Beckman), stomacher (AESAP 1068), shaker 
(Lab-Line), disperser (IKA T25), incubator (Utah State University), 48 well microtiter 
well plates (Becton Dickinson), brain heart infusion (BD), granulated agar (BD), and 
acetonitrile (HPLC grade, Thermo Fisher). Lactose (Proliant), molecular sieves (3A), 
anhydrous isopropanol, vinyl laurate, ethanol, Tween 20, and Tween 80 were from Sigma 
Aldrich. Immobilized lipases R. miehei (RM1, RM2 and RM3), Thermomyces 
launuginose (TM1, TM2 and TM3), Pseudomonas cepacia (PC1, PC2 and PC3), 
Candida antarctica (CA1), Candida rugosa (CR), Rhiyzopus oryzae (RO), and Candida 
antarctica B (CAB1 and CAB2) were from Sigma Aldrich. Phosphate buffer saline (PBS) 
(pH 7.4) was from Thermo Fisher. Palcam broth, agar base and supplements with 
polymixin B, acriflavine and ceftazidime were from Neogen. L. monocytogenes isolates 
(FSL C1-056, FSL J1-177, FSL N1-227, FSL N3-013, FSL R2-499) were obtained from 
Dr. Martin Wiedmann, director of the International Life Sciences Institute North 
American Database at Cornell University. Sterile milks (fat free, 1% fat and 1.5% fat) 
and cream (8% fat) were purchased from Gossner Foods, Inc (Logan UT). Drinkable 
yogurts (fat free, 1% fat and 1.5% fat) and cottage cheese (fat free and 2% fat made from 
cultured milk) were purchased locally.  
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LML Synthesis 
To set up a 3 mL LML synthesis reaction, 44 mg of lactose was added to 3 mL of 
anhydrous isopropanol with 10% dried molecular sieves, followed by the addition of 
0.124 mL of vinyl laurate and 90 mg of one of the 14 immobilized lipases. The reactions 
were assembled in 4 mL glass vials (Utah State University) and incubated on a shaker at 
55°C for 3 days. The reactions were analyzed at room temperature by the HPLC 
(Beckman System Gold 125 Solvent Module) equipped with a Luna 5 micron C18 (2) 
100 Å column (250 mm × 4.6 mm, Phenomenex, Torrance, CA, USA). The mobile phase 
consists of a gradient from 10% acetonitrile: water (40:60) to 100% acetonitrile: water 
(95:5), with a flow rate of 1.0 mL/min over 24 minutes. Products and standards were 
detected with an evaporative light scattering detector at 60 °C with a nitrogen gas  
pressure of 3.65 bar.   
Inoculum Preparation 
Five strains of L. monocytogenes (FSL C1-056, FSL J1-177, FSL N1-227, FSL 
N3-013, FSL R2-499) were used in antimicrobial testing in dairy products.  Freezer 
stocks were kept at -80°C. An aliquot of each freezer stock, 20 µL, was transferred into 
15 mL of fresh BHI media and was grown with shaking at 37°C for 24 hours.  The 
optical density (OD) at 600 nm for each strain was adjusted to 0.2 with BHI media.  
The 5-strain cocktail was prepared by mixing 2 mL aliquots of each strain into a 
sterile, 50 mL centrifuge tube. Phosphate-buffered saline solution (100 mL) was added 
and the sample was centrifuged (3000 RPM for 10 minutes).  The cell precipitate was re-
suspended in 10 mL of PBS and centrifuged, then re-suspended and centrifuged again.  
The 5-strain cocktail stock was kept at -20°C.  
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Freezer stocks of all microorganisms were kept at -20°C prior to growth in BHI 
media at 37°C. After 1 hour of thawing, 100 µL of culture was inoculated into 15 mL of 
BHI media.  Cells were grown with shaking at 37°C for 24 hours. The overnight culture, 
315 µL, was subcultured into 12 mL of BHI media, and incubated in a shaker at 37°C for 
4 hours. The OD of the culture was measured by using the spectrophotometer at 600 nm.  
When the OD approached 0.2 nm, an aliquot of 30 µL was subcultured again into 30 mL  
of BHI media and this was used in the experiments.  
Antibacterial Test on L. monocytogenes N3-013 in BHI Media Treatments	  were	  created	  with	  LML,	  lauric	  acid,	  lactose,	  and	  Tween	  20	  using	  20	  mg/mL	  stocks in 50% of ethanol-water, with ethanol-water as a control with L. 
monocytogenes N3-013. L. monocytogenes was grown as described above for the 5-strain 
cocktail. The total volume of each replicate was 0.5 mL. The concentrations of treatments 
were 0.01, 0.05, 0.1, 1, 3 and 5 mg/mL. The final ethanol content of 6 concentrations in 
both treatment and controls were 0.025%, 0.125%, 0.25%, 2.5%, 7.5% and 12.5% 
respectively.  For each concentration of LML, lauric acid, and Tween 20, there were 6 
replicates for both control and treatment. Microtiter well plates were incubated in a 
shaker at 37°C for 24 hours.  The number of cells in each treatment was determined by 
enumeration via plate counts. A t-test of the controls and the treatments was done to  
determine significance. 
Antibacterial Test in Dairy Products  
The 5-strain cocktail stock, 100 µL, was inoculated into 15 mL of BHI media and 
grown with shaking at 37°C for 24 hours.  An aliquot, 315 µL, was subcultured into 12 
mL of BHI media, then incubated in a shaker at 37°C for 4 hours. When the OD 
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approached 0.2, an aliquot, 30 µL, was subcultured again into 30 mL each of sterile milk, 
yogurt, and cottage cheese. LML (in 50% ethanol:water) was added to samples at 
concentrations of 1, 3, or 5 mg/mL for milk and 3 and 5 mg/mL for yogurt and cottage 
cheese. The total volume of each sample was 0.5 mL.  For each concentration of LML, 
there were 6 replicates for both control (50% ethanol: water solution) and treatment. The 
final ethanol concentration in 1, 3, and 5 mg/mL of both treatment and controls were 
2.5%, 7.5%, and 12.5% respectively. Microtiter well plates were incubated in a shaker at 
37°C or in a fridge at 5°C for 24 hours. Cells were diluted with PBS solution and plated 
onto a PALCAM agar plate, and incubated at 37°C. Cells were enumerated via plate 
counts after 24 hours. Prior to antimicrobial testing, the cottage cheese was homogenized 
via a stomacher. A t-test of the controls and the treatments was done to determine  
significance. 
Homogenization  
Five milliliter of whole milk was kept at 50 °C in a 15 mL sterile tube. Add 25 or 
40 mg of dry LML products into the aliquot. LML was homogenized into milk sample by 
using a disperser (IKA T 25 digital ULTRA-TURRAX) for 5 minutes (25000 RPM).  
The homogenization procedure was done in a biosafety cabinet. All equipment used in  
homogenization were required to be sterilized. 
Probiotics Test of Dairy Products 
Fat-free yogurt and cottage cheese were treated with or without 5 mg/mL of LML. 
The total volume of each sample was 0.5 mL. Six replicates for both control and 
treatment were added into microtiter well plates and incubated in a shaker at 37°C for 24 
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hours.  Cells were diluted using PBS solution, then 0.1 mL of the diluted aliquot was 
placed onto a LB agar plate and incubated at 37°C for 24 hours. Total cells (probiotic)  
were enumerated via plate counts after 24 hours without LML treatment. 
Confirmation of VBNC State of L. monocytogenes 
The L. monocytogenes 5-strain cocktail was cultured in BHI media with 5 mg/mL 
of LML for 24 hours. The treated cultures were diluted 0, 10, 50, 100 and 1000 fold, and 
allowed to grow at both 37°C and 5°C.  The number of cells via plate counts was 
determined once a week for 6 weeks.  
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RESULTS AND DISCUSSION 
Synthesis of LML 
Immobilized lipases were used to synthesize LML. The immobilized enzyme 
technique can allow enzymes to be held in place throughout the reaction, following which 
they are easily separated from the products and can be used again, thus helping cut the 
synthesis cost.  
This synthesizing reaction is a reversible, esterification reaction, so the reaction 
should proceed in the absence of water. With lipases, the esterification reaction takes 
place under non-aqueous conditions, while the hydrolysis reaction takes place under 
aqueous conditions. 
Different kinds of lipases were used to synthesis LML. The yield of LML was 
measured by HPLC after 3 days. Enzymes RM1, TM3, and PC2 were the top three 
highest yield of final product (Table 2). In terms of purity, TM3 and PC2 were more 
satisfactory, since these two lipases had less impurity peaks. Therefore, TM3 and PC2 
were chosen to use in the further synthesizing experiments. 
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Table 2. Yield of synthesized LML of each enzyme after 3-day reaction 
S/No Enzyme 
LML Peak 
Area 
LML Peak 
Area % 
Total 
Number of 
Peaks 
Numbers 
of LML 
Peaks 
Amount of 
LML 
mg/mL 
1 RM1 5.539 47.567 4 1 5.54 
2 RM2 2.52 25.71 7 1 1.09 
3 RM3 0 0 2 0 0 
4 TM1 1.78 34.2 4 1 0.72 
5 TM2 0.7289 46.68 3 1 0.26 
6 TM3 7.89 88.08 3 1 3.59 
7 PC1 0.40 23.22 3 0 0.1 
8 PC2 6.31 100 1 1 2.85 
9 PC3 0.83 41.04 3 1 0.3 
10 RO 0 0 1 0 0 
11 CR 0 0 1 0 0 
12 CA1 2.70 77.55 2 0 1.18 
13 CAB1 0 0 0 0 0 
14 CAB2 0 0 0 0 0 
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Antibacterial Test on L. monocytogenes N3-013 in BHI Media 
Previous research from Wagh et al. (2012) showed that LML inhibited the growth 
of 5 isolates of L. monocytogenes. This	  paper	  prompted	  the	  decision to use up to 5 mg/mL 
of LML as treatment in dairy products.   
Lactose, lauric acid (Figure 3) and Tween 20 (Figure 4) were used to determine 
which moiety of LML was responsible for its bactericidal activities. Tween 20 is a sugar 
ester (sorbitan monolaurate) similar to LML, and it can also be used as an emulsifier. So, 
testing Tween 20 and comparing it with LML showed the influence of the sugar on the 
antibacterial effect. 
	  
Figure 3. Structure of lauric acid. 
	  
Figure 4. Structure of Tween 20. 
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LML started to show an inhibitory effect at 0.01 mg/mL (0.02 mM) and had a 
bactericidal effect at 5 mg/mL (Figure 5). The MBC was between 3 (5.7 mM) and 5 
mg/mL (9.5 mM). The MIC of LML was lower than the result from Wagh et al., (2012), 
but the MBC conformed with their results. With 5 mg/mL of LML, a 4.3 ± 0.04 log 
reduction of Listeria was achieved (raw data is given in appendix A).  
	  
Figure 5. Average counts (log CFU/mL) of L. monocytogenes N3-013 treated with 0.01, 
0.05, 0.1, 1, 3 or 5 mg/mL of LML in BHI media after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation  
and the asterisks indicate significant difference between control and treatment. 
Lactose had no effect on inhibiting Listeria. There were no significant difference 
between control and treatment after 24 hours (data not shown). Lauric acid showed a 
similar result as LML, but the antibacterial effect was not as great as LML (Figure 6). 
The MIC of lauric acid was 0.1 mg/mL (0.5 mM) and the MBC was greater than 5 
mg/mL. Some bacteria survived after being treated with 5 mg/mL of lauric acid. The log 
reduction of Listeria was 3.5 ± 0.2.  
Monolaurin (glyceryl monolaurate), as an emulsifier, can be added into food. 
Wang et al. (1992) found that the MBC of monolaurin against L. monocytogenes in BHI 
was 10 to 20 mg/mL. In Nobmann et al. (2009), lauric ester of methyl alpha-D-
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glucopyranoside and lauric ester of methyl alpha-D-mannopyranoside showed the 
highest growth-inhibitory effect with MIC values of 0.04 mM against L. monocytogenes, 
which was similar to the MIC reported in this paper (0.02 mM). The MIC for lauric acid 
in their studies with L. monocytogenes ranged from 0.63 to 1.25 mM, which was higher 
than the lauric esters, and was close to the MIC reported here (0.5 mM). 
	  
Figure 6. Average counts (log CFU/mL) of L. monocytogenes N3-013 treated with 0.01, 
0.05, 0.1, 1, 3 or 5 mg/mL of lauric acid in BHI media after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation  
and the asterisks indicate significant difference between control and treatment. 
Tween 20 showed a bacteriostatic effect when the concentration of treatment was 
5 mg/mL and the log reduction of Listeria was only 1.6 ± 0.08	   (Figure 7). In Figures 5, 6 
and 7, 5 mg/mL of control (50% of ethanol) resulted in a significant decrease compared 
with 3 mg/mL of control, which was because of the difference between the ethanol 
concentrations. The final ethanol contents of 3 and 5 mg/mL controls were 7.5% and 
12.5%. In 5 mg/mL of control, the final ethanol concentration was almost twice that in 3 
mg/mL of control, so the larger amount of ethanol killed much more bacteria than 3 
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mg/mL of control. However, 5 mg/mL of LML could still achieve a 4.3 log reduction, 
which still showed significant bactericidal properties.  
 
Figure 7. Average counts (log CFU/mL) of L. monocytogenes N3-013 treated with 0.01, 
0.05, 0.1, 1, 3 or 5 mg/mL of Tween 20 in BHI media after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation  
and the asterisks indicate significant difference between control and treatment. 
As with the Smith et al. (2009) study, they also found that the carbohydrate 
moiety is involved in the antimicrobial activity of the sugar esters and that the nature of 
the bond (ether or ester between the sugar and fatty acid) also has a significant effect on 
efficacy.  The MBC and MIC of LML is lower than that for a similar sugar ester, Tween-
20, and similar to lauric acid, therefore it is believed that the lauric acid is the critical 
moiety for bactericidal activity and the lactose influences this activity. Therefore, lauric 
acid moiety conveyed the antibacterial properties of LML. The type of sugar attached to 
the lauric acid and the degree of esterification results in different antibacterial properties.  	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Antibacterial Test in Milk and Cream  
When testing the in dairy products, a L. monocytogenes 5-strain cocktail was 
inoculated into the products. Testing a 5-strain cocktail instead of a single strain made it 
more practical since it is very possible to have more than one isolate growing in products. 
To test the antibacterial effect of LML, it was necessary to simulate a potentially real 
situation of Listeria contamination in a food system. The initial inoculating concentration 
of Listeria was 5 log CFU/mL, which is a very severe contamination level that could 
almost never happen in real life. So, a 4 log reduction of Listeria can be considered very 
effective.   
In the milk experiment, 1, 3 and 5 mg/mL of LML were used. This was based on 
the results from the growth media experiment, which showed that 0.01, 0.1 and 0.5 
mg/mL of LML did not have significant inhibitory effects. In fat free milk, 5 mg/mL of 
LML showed a bactericidal effect on the growth of Listeria (raw data is given in 
appendix B). A 4.45 ± 0 log reduction was achieved (Figure 8).  
	  
Figure 8. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 1, 3 or 5 mg/mL of LML in fat-free milk after 24 hours. The black bars are controls 
and the grey bars are treatments. The error bars represent the standard deviation and the 
asterisks indicate significant difference between control and treatment
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With low-fat and whole milk, 5 mg/mL (9.5 mM) of LML inhibited the growth of 
Listeria significantly, but LML was not bactericidal (Figures 9, 10). The log reductions at 
5 mg/mL of Listeria in these two milks were 4.01 ± 0.13 and 4.25 ± 0.10. LML had no 
inhibitory effect on Listeria in cream (8% fat) at concentrations up to 5 mg/mL of LML 
(data not shown). These results were similar to previous results of antibacterial tests of 
LML in BHI media on single strain of L. monocytogenes. With each concentration, there 
is a corresponding control that contains the same amount of ethanol, which in itself 
inhibited the growth of L. monocytogenes in certain level. The antimicrobial effect in the 
3 and 5 mg/mL samples may have been due to the compounding stress of both the 
ethanol and the LML.  
	  	   	  
Figure 9. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 1, 3 or 5 mg/mL of LML in low-fat milk after 24 hours. The black bars are controls 
and the grey bars are treatments. The error bars represent the standard deviation and the 
asterisks indicate significant difference between control and treatment. 
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Figure 10. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 1, 3 or 5 mg/mL of LML in whole milk after 24 hours. The black bars are controls 
and the grey bars are treatments. The error bars represent the standard deviation and the 
asterisks indicate significant difference between control and treatment. 
The antibacterial effect of LML was related to the fat content of the dairy 
products. Because of the amphipathic nature of LML, it may have partially dissolved into 
the fat phase of low-fat milk, whole milk, and cream. As a result, there were less LML in 
the system can be used to kill bacteria. So, the higher the fat content in the products, the 
weaker the bacteriostatic effect of LML will become.  
Directly homogenizing LML into dairy reduced its antibacterial effect. Our results 
showed that 5 mg/mL of LML did not have significant inhibitory effect on Listeria in 
whole milk (data not shown). Based on this result, the concentration of LML was raised 
up to 8 mg/mL. However, 8 mg/mL of LML, which was higher than the maximum usage 
level that USDA regulation (5 mg/mL), did not have bactericidal effect on L. 
monocytogenes. Another possible reason leaded this unsatisfactory result was because of 
the contamination of the sample. Therefore, homogenize LML directly into milk was 
considered infeasible. 
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Antibacterial Test in Drinkable Yogurt  
Based on the results from the milk experiments, 1 mg/mL of LML did not have a 
significant bacteriostatic effect. So, in the drinkable yogurt and cottage cheese 
experiments, only 3 and 5 mg/mL of both control and treatment were used. 
In fat free and 1% fat drinkable yogurt, 5 mg/mL (9.5 mM) of LML killed all the 
viable Listeria corresponding to a 4.08 ± 0 and 4.35 ± 0.77 log reduction respectively 
(Figures 11, 12) (raw data is given in appendix C). Because of the increasing of fat 
content in 1.5% fat yogurt, 5 mg/mL of LML showed a bacteriostatic effect and resulted 
a 3.54 ± 0.31 log reduction in Listeria (Figure 13).  The antibacterial effects of LML in 
yogurt were similar to the effects in milk. However, the control cells of yogurt were 
lower than milk, which may because of the different growth environment for Listeria. 
Listeria grows at pH values between 4.3 and 9.4 with an optimum at pH 7 (Faber and 
Peterkin, 1991). Since the pH value of milk was around 7, more Listeria control cells 
grew in milk than in yogurt (pH valued around 4.5).  
	  
Figure 11. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 3 or 5 mg/mL of LML in fat-free drinkable yogurt after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation 
and the asterisks indicate significant difference between control and treatment.
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Figure 12. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 3 or 5 mg/mL of LML in 1% fat drinkable yogurt after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation 
and the asterisks indicate significant difference between control and treatment. 
 
	  
Figure 13. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 3 or 5 mg/mL of LML in 1.5% fat drinkable yogurt after 24 hours. The black bars 
are controls and the grey bars are treatments. The error bars represent the standard 
deviation and the asterisks indicate significant difference between control and treatment. 
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Since the yogurt used in this research contained probiotics (Lactobacillus reuteri 
and Biodobacterium lactis), it was necessary to measure the CFU/mL of the probiotics in 
each yogurt to determine whether LML had any bacteriostatic effect on the probiotics. 
Average count of probiotics in fat free yogurt was 7.33 log CFU/mL. After treated with 5 
mg/mL of LML for 24 hours, there were no viable probiotics. Therefore, LML killed all 
the viable Listeria and the probiotics in fat-free and 1% fat drinkable yogurt, and is  
bacteriostatic in 1.5% fat drinkable yogurt.  
Antibacterial Test in Cottage Cheese  
In fat-free and 2% fat cottage cheese, there was no viable Listeria culture after 
being treated with 5 mg/mL (9.5 mM) of LML (Figures 14, 15). The log reduction of 
Listeria in both cottage cheese after being treated for 24 hours were 4.0 ± 0.17 and 4.05 ± 
0.13 respectively (raw data is given in appendix D).  
	  
Figure 14. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 3 or 5 mg/mL of LML in fat-free cottage cheese after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation 
and the asterisks indicate significant difference between control and treatment
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Figure 15. Average counts (log CFU/mL) of L. monocytogenes 5-strain cocktail treated 
with 3 or 5 mg/mL of LML in 2% fat cottage cheese after 24 hours. The black bars are 
controls and the grey bars are treatments. The error bars represent the standard deviation 
and the asterisks indicate significant difference between control and treatment. 
Similar to yogurt, growth of the control cells in cottage cheese was lower than in 
milk, which may have been due to the low pH value of cheese (around 5.1). The cottage 
cheese also contained probiotics, and the average CFU/mL of the probiotics was 7 log 
CFU/mL. After being treated with 5 mg/mL of LML for 24 hours, there were no 
probiotics.  Therefore, LML killed all the viable Listeria and the probiotics in fat free and 
2% fat cottage cheese, and is bacteriostatic in 1.5% fat drinkable yogurt.  In summary, 5 
mg/mL of LML killed all the Listeria in several dairy products and could achieve a 4 log 
reduction.  
Sugar ester as an emulsifier should be mixed or homogenized into dairy products 
to decrease droplet size or air bubble size and to get the emulsifier distributed on the 
surface of the interface (Tual et al., 2006). Another concern is the ethanol content in dairy 
products. With 5 mg/mL of LML, the final ethanol concentration is 12.5%. Whether this
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high content of ethanol in diary products would affect the flavor or shelf life is unknown. 
For further study, reducing the ethanol content by improving synthesizing technology  
needs to be done. Sensory testing is also necessary in further study. 
Antimicrobial Test at 5°C 
Dairy products are usually kept in a refrigerator. Therefore, antibacterial tests 
should also be done at refrigeration temperature. Additionally, LML is a fatty acid ester, 
and the solubility of ester is temperature related. Previous research has noted that LML 
only dissolves in warm water or in a binary solvent with equal volumes of ethanol and 
water only at 22°C or higher. In order to keep LML completely dissolved, this 
experiment needs to be conducted under room temperature. Otherwise, while using 
partially dissolved LML, the antibacterial effect will be reduced significantly.  
Five mg/mL of LML were treated in each kind of dairy product and were 
cultivated at refrigeration temperature (5°C). However, the result was not satisfactory 
(data not shown). There was no significant inhibition on Listeria growth. To use LML in 
dairy products, the treated products need to be kept at room temperature. However,   
keeping dairy products at room temperature will shorten their shelf life.  
Confirmation of VBNC State of L. monocytogenes 
L. monocytogenes has been reported to enter a VBNC state when exposed to 
stress conditions such as resource depletion, extreme temperature, high osmolarity and 
pressure (Oliver, 2005; Dreux et al., 2007).	  The morphology of L. monocytogenes 
changed from the normal rod shape to cocci in chains when exposed to LML at 1 mg/mL, 
which is consistent with a stressed state (Wen et al., 2009; Wagh et al., 2012).  Therefore, 
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the hypothesis that L. monocytogenes was not in a VBNC state when treated with LML 
was tested.	  Five isolates of L. monocytogenes cocktail were treated with 5 mg/mL LML 
and was diluted to reduce the effect of surfactant. Dilutions up to 1000 fold resulted in 10 
to 100 CFU/mL and 5 mg/mL LML. The culture was allowed to keep growing for 6 
weeks at both 37°C and 5°C, and cells were enumerated once a week. No viable Listeria 
culture was detected for up to 6 weeks (data not shown). Five mg/mL of LML effectively 
inhibited the VNBC state of L. monocytogenes. 
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CONCLUSIONS 
The immobilized lipases TM3 and PC2 were the two most effective immobilized 
lipases to synthesis LML. Lauric acid moiety is responsible for the bacteriostatic effect of 
LML. The type of sugar used to synthesize sugar ester and the degree of esterification 
leads to different antibacterial properties.  
Five mg/mL of LML can effectively inhibit the growth of L. monocytogenes in 
growth media and can achieve approximately a 4 log reduction in dairy products. The 
MBC of LML on Listeria was between 3 and 5 mg/mL.  
With fat-free milk, fat-free drinkable yogurt, 1% fat drinkable yogurt, fat-free 
cottage cheese, and 2% fat cottage cheese, 5 mg/mL of LML killed all the viable Listeria 
culture corresponding to a 4 to 4.45 log reduction.  With low-fat milk, whole milk, and 
1.5% fat drinkable yogurt, LML had a bacteriostatic effect and achieved a 3.54 to 4.01 
log reduction of Listeria. LML did not show significant inhibition on Listeria in cream. 
The antibacterial effect of LML was related to the fat content of the dairy products. With 
a higher content of fat, the antibacterial effect was weaker due to the amphipathic nature 
of LML.  
Since LML is a sugar ester, its solubility is temperature related. LML only 
dissolved in warm conditions. Therefore, LML did not show a bacteriostatic effect at 
5 °C.  
Five mg/mL of LML can inhibit the VBNC state of Listeria for up to 6 weeks. 
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FUTURE RESEARCH 
Although sugar ester has been reported tasteless and odorless, the effect of adding 
LML into dairy products on the taste is still known. A sensory to investigate on the taste, 
texture and odor of the dairy products with LML is necessary in future research. Studies 
of the antibacterial effect of LML in other kind of food such as meat can also be done in 
future.  
With 5 mg/mL of LML, the ethanol content was 12.5%, which was had microbial 
inhibitory effects. Recent research has shown that the ethanol content of the solvent o to 
solubilize LML can be reduced by adding dimethyl sulfoxide (DMSO). 
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Appendix A.  Antibacterial Test on L. monocytogenes N3-013 in BHI Media 
Antibacterial effect of LML (Control) on L. monocytogenes N3-013 in BHI Media  
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
0.01 9.05 0.02 
0.05 9.47 0 
0.1 9.30 0 
1 9.35 0.06 
3 9.36 0.03 
5 4.30 0.05 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML (Treatment) on L. monocytogenes N3-013 in BHI Media  
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
0.01 7.78 0 
0.05 7.85 0 
0.1 5.80 0.012 
1 5.42 0.024 
3 3.78 0.12 
5 0 0 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML on L. monocytogenes N3-013 in BHI Media  
Concentration 
(mg/mL) 
0.01 0.05 0.1 1 3 5 
P-value 0.001 <0.0001 <0.0001 0.0005 0.001 0.0002 
 
 
 
 
 
 	  
38 
 
Antibacterial effect of Lauric Acid (Control) on L. monocytogenes N3-013 in BHI Media  
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
0.01 9.95 0.07 
0.05 9.70 0.17 
 
0.1 9.64 0.14 
1 8.82 
 
0.19 
3 7.16 0.09 
5 3.58 0.20 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of Lauric Acid (Treatment) on L. monocytogenes N3-013 in BHI 
Media  
Concentration of Lauric 
Acid (mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
0.01 9.37 0.14 
0.05 9.09 0.15 
0.1 6.28 
 
0.16 
 
1 5.66 
 
0.08 
 
3 3.87 
 
0.72 
 
5 0.10 
 
0.09 
 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of Lauric Acid on L. monocytogenes N3-013 in BHI Media  
Concentration 
(mg/mL) 
0.01 0.05 0.1 1 3 5 
P-value 0.01 0.11 0.001 <0.0001 <0.0001 0.0008 
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Antibacterial effect of Tween 20 (Control) on L. monocytogenes N3-013 in BHI Media  
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
0.01 9.32 0.01 
0.05 9.41 0.21 
0.1 9.52  0.06 
1 9.73  0.01 
3 9.63 0.018 
5 4.48  0.08 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of Tween 20 (Treatment) on L. monocytogenes N3-013 in BHI Media  
Concentration of Tween 20 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
0.01 9.36 0 
0.05 9.3 0.01 
0.1 6.455 0.06 
1 5.51 0.18 
3 4.91 0.31 
5 2.89 2.89 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of Tween 20 on L. monocytogenes N3-013 in BHI Media  
Concentration 
(mg/mL) 
0.01 0.05 0.1 1 3 5 
P-value 0.095 0.76 0.0009 0.004 0.008 0.014 
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Appendix B.  Antibacterial Test on L. monocytogenes 5 Clinical Isolates Cocktail in 
Milk Products 
Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in Fat-Free Milk 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
1 9.35 0.057 
3 9.355 0.03 
5 4.3 0.047 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in Fat-Free Milk 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
1 8.23 0.38 
3 5.29 0.4 
5 0 0 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in Fat-Free 
Milk 
Concentration 
(mg/mL) 
1 3 5 
P-value 0.60 0.04 <0.0001 
Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in Low-Fat Milk 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
1 8.62 0.088 
3 7.77 0.037 
5 4.90 0.074 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in Fat-Free Milk 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
1 8.11 0.54 
3 5.28 0.032 
5 0.89 0.27 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in Low-Fat 
Milk 
Concentration 
(mg/mL) 
1 3 5 
P-value 0.27 0.0002 0.002 
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Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in Whole Milk 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
1 8.625 0.09 
3 6.64 0.057 
5 4.7 0 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in Whole Milk 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
1 8.42 0.057 
3 5.8 0.28 
5 0.45 0.212 
Error represents the standard deviation divided by square root of sample size.
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Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in Whole 
Milk 
Concentration 
(mg/mL) 
1 3 5 
P-value 0.115 0.05 0.039 
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Appendix C.  Antibacterial Test on L. monocytogenes 5 Clinical Isolates Cocktail in 
Drinkable Yogurt 
Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in fat-free drinkable yogurt 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 4.43 0.72 
5 4.08 0 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in fat-free drinkable yogurt 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 3 0.62 
5 0 0 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in fat-free 
drinkable yogurt 
Concentration (mg/mL) 3 5 
P-value 0.19 0.006 
Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in 1% fat drinkable yogurt 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 5.16 0.16 
5 4.35 0.77 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in 1% fat drinkable yogurt 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 3.767 0.57 
5 0 0 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in 1% fat 
drinkable yogurt 
Concentration (mg/mL) 3 5 
P-value 0.15 0.0003 
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Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in 1.5% fat drinkable yogurt 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 3.53 0.19 
5 3.845 0 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in 1.5% fat drinkable yogurt 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 3 0.55 
5 0.31 0.31 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in 1.5% fat 
drinkable yogurt 
Concentration (mg/mL) 3 5 
P-value 0.034 0.001 
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Appendix D.  Antibacterial Test on L. monocytogenes 5 Clinical Isolates Cocktail in 
Cottage Cheese 
Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in fat-free cottage cheese 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 6.477 0.30 
5 4 0.17 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in fat-free cottage cheese 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 4.30 0.36 
5 0 0 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in fat-free 
cottage cheese 
Concentration (mg/mL) 3 5 
P-value 0.024 0.0004 
Antibacterial effect of LML (Control) on L. monocytogenes 5 Clinical Isolates Cocktail 
in 2% fat cottage cheese 
Concentration of Control 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 4.61 0.70 
5 4.04 0.13 
Error represents the standard deviation divided by square root of sample size. 
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Antibacterial effect of LML (Treatment) on L. monocytogenes 5 Clinical Isolates 
Cocktail in 2% fat cottage cheese 
Concentration of LML 
(mg/mL) 
Average Counts 
 (log CFU/mL) 
Error 
3 4.55 0.54 
5 0 0 
Error represents the standard deviation divided by square root of sample size. 
Antibacterial effect of LML on L. monocytogenes 5 Clinical Isolates Cocktail in 2% fat 
cottage cheese 
Concentration (mg/mL) 3 5 
P-value 0.63 0.0002 
 
 
 
 
 
 
